These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 32498943)

  • 1. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
    Cheng X; Chen M; Liu Z
    Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
    Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ
    Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8.
    Cheng Y; Liu N; Yang C; Jiang J; Zhao J; Zhao G; Chen F; Zhao H; Li Y
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1272. PubMed ID: 32441881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
    Chen K; Zhang L
    J Cell Biochem; 2019 Sep; 120(9):14431-14443. PubMed ID: 31081143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
    Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
    J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
    Su Y; Xie R; Xu Q
    Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-370 functions as a tumor suppressor in hepatocellular carcinoma via inhibition of the MAPK/JNK signaling pathway by targeting BEX2.
    Wang X; Zhu W; Xu C; Wang F; Zhu X; Sun Y; Guo Y; Fu X; Zhang Y; Zang Y
    J Hum Genet; 2019 Dec; 64(12):1203-1217. PubMed ID: 31530937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
    Sun W; Zhang Z; Wang J; Shang R; Zhou L; Wang X; Duan J; Ruan B; Gao Y; Dai B; Qu S; Liu W; Ding R; Wang L; Wang D; Dou K
    Oncotarget; 2016 Mar; 7(10):11595-608. PubMed ID: 26871477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
    Ren F; Su H; Jiang H; Chen Y
    J Cell Biochem; 2020 Jan; 121(1):213-223. PubMed ID: 31190447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of LncRNAH19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway.
    Lv J; Ma L; Chen XL; Huang XH; Wang Q
    J Huazhong Univ Sci Technolog Med Sci; 2014 Jun; 34(3):363-369. PubMed ID: 24939300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma.
    Li Z; Wang Y
    Biochem Cell Biol; 2018 Jun; 96(3):365-371. PubMed ID: 28892647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 19. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY; Hu M; Zhao L; Guo WS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.